Evaluating the clinical impact of integrating a computerized clinical decision support system and a social robot into discussion of patient cases with the care team

Impact of computerized clinical decision support system and socially assistive humanoid robots in grand round routine, during pre/post-operative care of patients with vascular and thoracic diseases and conditions: a randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN12048782

Enrollment

200

Registered

2022-02-28

Start date

2022-06-01

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impact of robot delivered computerized clinical decision support system on health quality measures and the quality of life of patients with vascular and thoracic diseases and conditions compared to control. Other

Interventions

Each participant will be followed during 3-5 days’ stay in the ward

during the preparation, procedure, and post-procedure care. Eligible participants will be informed of the characteristics of the study and provided with an informed consent form. To those who will con

instead, only standard workflow and progression charts are utilized). Blinding is achieved by handling the same tools at the grand and work rounds (Robot, Tablets). However, in the control group, t

in all in-patients, blood pressure is recorded daily (standing order) and recorded on a progression chart. In the Intervention Group the CCDS and CPS are used to flag deviations from 150/ 90 mmHg stan

in all in-patients, VAS (10 cm) is recorded on daily basis (standard procedure) and recorded on a progression chart. In the Intervention Group the CCDS and CPS are used to flag all VAS values of 5 and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. In-patients in Vascular Surgery and Thoracic Surgery wards 2. Over the age of 18 years 3. Without any major psychological disorders 4. Capable of signing the letter of consent

Exclusion criteria

Exclusion criteria: 1. Emergency patients 2. Patients without consent 3. Patients already randomized on either vascular or thoracic surgery ward (no-double enrolment) 4. Patients with Abbreviated Mental Test score 6 or lower 5. Patients with special needs or appointed guardians 6. Patients allocated to an intensive step-down unit and/or regimen are excluded

Design outcomes

Primary

Measure	Time frame
Measured at the end of the study: 1. Clinical usability of the CDSS system measured with a System Usability Scale (SUS) 2. Acceptance of the CDSS system measured with a unified theory of acceptance and use of technology and its extension (UTAUT and UTAUT2)	—

Secondary

Measure	Time frame
Measured twice per day during hospital stay: 1. Health Quality Measures: blood pressure (sphygmomanometer) and heart-rate (clinician) 2. Pain level VAS (10 cm) 3. Patient reported outcome measure: EQ - 5D (quality of life)	—

Countries

Slovenia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026